Biosensors are utilized in several different fields, including medicine, food, and the
environment; in this review, we examine recent developments in biosensors for healthcare …

Recent advances in technology are expected to increase our current understanding of
neuroscience. Nanotechnology and nanomaterials can alter and control neural functionality …

MicroRNAs in exosomes (exosomal miRNAs) have attracted increased attention as cancer
biomarkers for early diagnosis and prognosis owing to their stability in body fluids. Since …

Alzheimer's disease (AD) is a chronic neurodegenerative disorder associated with
dementia. To overcome the limitations of diagnosis and treatment nanotechnology research …

Accurate detection of mutiple biomarkers in unprocessed blood via lateral flow
immunoassay (LFA) strips remains challenging. Herein, we reported a novel surface …

Nowadays, the development of new technological solutions in the medical field, in particular
biosensors, is a priority and a ground for great scientific and financial investment. From …

The rapid and direct detection of biomarkers in biofluids at clinically relevant concentrations
faces serious limitations to develop diagnostic criteria for neurodegenerative diseases such …

Localized surface plasmon resonance (LSPR)-based biosensors have recently garnered
increasing attention due to their potential to allow label-free, portable, low-cost, and real …

Abstract Alzheimer's disease (AD), the most common neurologic disorder, is characterized
by progressive cognitive impairment. However, the low clinical significance of the currently …

Alzheimer's disease (AD) is a neurodegenerative disease that causes cognitive impairments
in areas such as memory, language, and reasoning. Currently, a definitive diagnosis of AD …